Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study

References

• Andre FE, Booy R, Bock HL Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008 Feb;86(2):140–146.
   PubMed Web of Science ®Google Scholar
• Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130433.
   PubMed Web of Science ®Google Scholar
• Carroll S, Rojas AJ, Glenngard AH Vaccination: short- to long-term benefits from investment. J Mark Access Health Policy. 2015;3.
   Google Scholar
• Largeron N, Levy P, Wasem J Role of vaccination in the sustainability of healthcare systems. J Mark Access Health Policy. 2015;3.
   Google Scholar
• Postma MJ, Carroll S, Brandao A. The societal role of lifelong vaccination. J Mark Access Health Policy. 2015;3.
   Google Scholar
• Quilici S, Smith R, Signorelli C. Role of vaccination in economic growth. J Mark Access Health Policy. 2015;3.
   Google Scholar
• Remy V, Zollner Y, Heckmann U. Vaccination: the cornerstone of an efficient healthcare system. J Mark Access Health Policy. 2015;3.
   Google Scholar
• Bonanni P, Picazo JJ, Remy V. The intangible benefits of vaccination - what is the true economic value of vaccination? J Mark Access Health Policy. 2015;3.
   Google Scholar
• World Health Organization. Guiding Principles for recovering, building resiliency, and strengthening of immunization in 2022 and beyond. 2022.
   Google Scholar
• European Commission. A European one health action plan against antimicrobial resistance (AMR). 2017.
   Google Scholar
• Zhou F, Shefer A, Wenger J Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014 Apr;133(4):577–585.
   PubMed Web of Science ®Google Scholar
• Boccalini S, Taddei C, Ceccherini V Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits. Hum Vaccin Immunother. 2013 May;9(5):1119–1128.
   Google Scholar
• Thompson KM, Tebbens RJ. Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal. 2006 Dec;26(6):1423–1440.
   PubMed Web of Science ®Google Scholar
• Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine. 2002 Jun 7;20(19–20):2562–2578.
   PubMed Web of Science ®Google Scholar
• Orenstein W, Offit P, Edwards KM Plotkin’s vaccines. 7th Edition ed.: Elsevier; 2017.
   Google Scholar
• Vaccination: Commission calls for stronger EU cooperation against preventable diseases [Internet]. 2018. Available from: https://ec.europa.eu/commission/presscorner/detail/en/IP_18_3457
   Google Scholar
• European Commission. Strengthened cooperation against vaccine preventable diseases. 2017.
   Google Scholar
• Courvoisier T, Charpentier B, van der Meer JWM Vaccination in Europe: an EASAC and FEAM commentary on the EC Roadmap ‘Strengthened cooperation against vaccine preventable diseases’
   Google Scholar
• The Lancet. Addressing decreasing vaccine coverage in the EU. Lancet. 2018 Apr 28;391(10131):1638.
   Web of Science ®Google Scholar
• Republic of Bulgaria National Council on Prices and Reimbursement of Medicinal Products. Ordinance on the terms, rules and procedure for regulation and registration of prices for medicinal products 2021. Available from: https://ncpr.bg/en/regulations/bulgarian-legislation/regulations.html
   Google Scholar
• Organisation for economic co-operation and development. OECD.Stat. Available from: https://stats.oecd.org/Index.aspx?ThemeTreeId=9
   Google Scholar
• European Commission. Exchange rate (InforEuro). Available from: https://ec.europa.eu/info/funding-tenders/procedures-guidelines-tenders/information-contractors-and-beneficiaries/exchange-rate-inforeuro_en
   Google Scholar
• European Medicines Agency. Zostavax 2016. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/zostavax
   Google Scholar
• Datapharm. VARIVAX 2022. Available from: https://www.medicines.org.uk/emc/product/5582/smpc
   Google Scholar
• European Medicines Agency. Use of Varilrix (live attenuated varicella virus [Oka strain]) to be harmonised in the EU 2021. Available from: https://www.ema.europa.eu/en/documents/referral/varilrix-article-30-referral-use-varilrix-live-attenuated-varicella-virus-oka-strain-be-harmonized_en.pdf
   Google Scholar
• European Medicines Agency. Menveo, INN-meningococcal Group A, C, W135 and Y conjugate vaccine. Available from: https://www.ema.europa.eu/en/documents/product-information/menveo-epar-product-information_en.pdf
   Google Scholar
• European Medicines Agency. Nimenrix 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/nimenrix
   Google Scholar
• European Medicines Agency. Bexsero 2022. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/bexsero
   Google Scholar
• European Medicines Agency. Trumenba, INN-Meningococcal group B vaccine. Available from: https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_en.pdf
   Google Scholar
• GlaxoSmithKline. Havrix junior vaccine 2020. Available from: https://gskpro.com/content/dam/global/hcpportal/en_CY/PDF/Homepage/Products/Havrix/smpc-havrix-720-junior-12-08-2020-en.pdf
   Google Scholar
• European Medicines Agency. HBVaxPro 2011. Available from: https://www.ema.europa.eu/en/documents/overview/hbvaxpro-epar-summary-public_en.pdf
   Google Scholar
• Ethgen O, Cornier M, Chriv E The cost of vaccination throughout life: a Western European overview. Hum Vaccin Immunother. 2016 Aug 2;12(8):2029–2037.
   PubMed Web of Science ®Google Scholar
• Ethgen O, Remy V, Wargo K. Vaccination budget in Europe: an update. Hum Vaccin Immunother. 2018;14(12):2911–2915.
   PubMed Web of Science ®Google Scholar
• Baron-Papillon F, Cornier M, Remy V What are the lifelong costs of vaccinating one individual? The French case. Value Health. 2014 Nov;17(7):A672.
   PubMed Web of Science ®Google Scholar
• Soler Soneira M, Olmedo Lucerón C, Sánchez-Cambronero Cejudo L El coste de vacunar a lo largo de toda la vida en España. Rev Esp Salud Pública. 2020;94:e202002005.
   PubMedGoogle Scholar